Publikationen von 0000-0001-5710-5127
(ORCID: 0000-0001-5710-5127)

Hertler, Caroline, Felsberg, Jörg, Gramatzki, Dorothee , Le Rhun, Emilie, Clarke, Jennifer , Soffietti, Riccardo, Wick, Wolfgang , Chinot, Olivier, Ducray, François, Roth, Patrick, McDonald, Kerrie, Hau, Peter, Hottinger, Andreas F., Reijneveld, Jaap, Schnell, Oliver, Marosi, Christine, Glantz, Michael, Darlix, Amélie, Lombardi, Giuseppe, Krex, Dietmar, Glas, Martin, Reardon, David A., van den Bent, Martin , Lefranc, Florence, Herrlinger, Ulrich, Razis, Evangelia, Carpentier, Antoine F., Phillips, Samuel, Rudà, Roberta, Wick, Antje , Tabouret, Emeline, Meyronet, David, Maurage, Claude-Alain, Rushing, Elisabeth, Rapkins, Robert, Bumes, Elisabeth, Hegi, Monika, Weyerbrock, Astrid, Aregawi, Dawit, Gonzalez-Gomez, Christian, Pellerino, Alessia , Klein, Martin, Preusser, Matthias , Bendszus, Martin, Golfinopoulos, Vassilis, von Deimling, Andreas, Gorlia, Thierry, Wen, Patrick Y., Reifenberger, Guido und Weller, Michael (2023) Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419). European Journal of Cancer 189, S. 112913. Volltext nicht vorhanden.

Le Rhun, Emilie, Devos, Patrick , Winklhofer, Sebastian, Lmalem, Hafida, Brandsma, Dieta, Kumthekar, Priya, Castellano, Antonella , Compter, Annette, Dhermain, Frederic, Franceschi, Enrico, Forsyth, Peter, Furtner, Julia, Galldiks, Norbert, Gállego Pérez-Larraya, Jaime, Gempt, Jens, Hattingen, Elke, Hempel, Johann Martin, Lukacova, Slavka, Minniti, Giuseppe, O’Brien, Barbara, Postma, Tjeerd J, Roth, Patrick , Rudà, Roberta, Schaefer, Niklas , Schmidt, Nils O, Snijders, Tom J, Thust, Steffi , van den Bent, Martin , van der Hoorn, Anouk , Vogin, Guillaume , Smits, Marion , Tonn, Joerg C, Jaeckle, Kurt A, Preusser, Matthias , Glantz, Michael, Wen, Patrick Y, Bendszus, Martin und Weller, Michael (2022) Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort. Neuro-Oncology 24 (10), S. 1726-1735. Volltext nicht vorhanden.

Stupp, Roger, Hegi, Monika E , Gorlia, Thierry, Erridge, Sara C, Perry, James, Hong, Yong-Kil, Aldape, Kenneth D, Lhermitte, Benoit, Pietsch, Torsten, Grujicic, Danica, Steinbach, Joachim Peter, Wick, Wolfgang, Tarnawski, Rafał, Nam, Do-Hyun, Hau, Peter, Weyerbrock, Astrid, Taphoorn, Martin J B, Shen, Chiung-Chyi, Rao, Nalini, Thurzo, László, Herrlinger, Ulrich, Gupta, Tejpal, Kortmann, Rolf-Dieter, Adamska, Krystyna, McBain, Catherine, Brandes, Alba A, Tonn, Joerg Christian, Schnell, Oliver, Wiegel, Thomas, Kim, Chae-Yong, Nabors, Louis Burt , Reardon, David A, van den Bent, Martin J , Hicking, Christine, Markivskyy, Andriy, Picard, Martin und Weller, Michael (2014) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology 15 (10), S. 1100-1108. Volltext nicht vorhanden.

Weller, M., Gorlia, T., Cairncross, J. G., van den Bent, M. J. , Mason, W., Belanger, K., Brandes, A. A. , Bogdahn, Ulrich, Macdonald, D. R., Forsyth, P., Rossetti, A. O. , Lacombe, D., Mirimanoff, R.-O., Vecht, C. J. und Stupp, R. (2011) Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology 77 (12), S. 1156-1164. Volltext nicht vorhanden.

Stupp, R., Tosoni, A., Bromberg, J. E. C., Hau, Peter, Campone, M., Gijtenbeek, J., Frenay, M., Breimer, L., Wiesinger, H., Allgeier, A., van den Bent, M. J. , Bogdahn, Ulrich, van der Graaf, W. , Yun, H. J., Gorlia, T., Lacombe, D. und Brandes, A. A. (2011) Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 22 (9), S. 2144-2149. Volltext nicht vorhanden.

Dhermain, Frederic G, Hau, Peter, Lanfermann, Heinrich, Jacobs, Andreas H und van den Bent, Martin J (2010) Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. The Lancet Neurology 9 (9), S. 906-920. Volltext nicht vorhanden.

Brandes, Alba A. , Stupp, Roger, Hau, Peter, Lacombe, Denis, Gorlia, Thierry, Tosoni, Alicia, Mirimanoff, Renè O., Kros, Johan M. und van den Bent, Martin J. (2010) EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma. European Journal of Cancer 46 (2), S. 348-354. Volltext nicht vorhanden.

Stupp, Roger, Hegi, Monika E. , Mason, Warren P., van den Bent, Martin J. , Taphoorn, Martin J. B., Janzer, Robert C., Ludwin, Samuel K., Allgeier, Anouk, Fisher, Barbara, Belanger, Karl, Hau, Peter, Brandes, Alba A. , Gijtenbeek, Johanna, Marosi, Christine, Vecht, Charles J., Mokhtari, Karima, Wesseling, Pieter , Villa, Salvador , Eisenhauer, Elizabeth, Gorlia, Thierry, Weller, Michael, Lacombe, Denis, Cairncross, J. Gregory und Mirimanoff, René-Olivier (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The lancet oncology 10 (5), S. 459-466. Volltext nicht vorhanden.

Reardon, D. A., Dresemann, G., Taillibert, S., Campone, M., van den Bent, M. , Clement, P., Blomquist, E., Gordower, L., Schultz, H., Raizer, J., Hau, Peter, Easaw, J., Gil, M., Tonn, J., Gijtenbeek, A., Schlegel, U., Bergstrom, P., Green, S., Weir, A. und Nikolova, Z. (2009) Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. British journal of cancer 101 (12), S. 1995-2004. Volltext nicht vorhanden.

Stupp, Roger, Mason, Warren P., van den Bent, Martin J. , Weller, Michael, Fisher, Barbara, Taphoorn, Martin J. B., Belanger, Karl, Brandes, Alba A. , Marosi, Christine, Bogdahn, Ulrich, Curschmann, Jürgen, Janzer, Robert C., Ludwin, Samuel K., Gorlia, Thierry, Allgeier, Anouk, Lacombe, Denis, Cairncross, J. Gregory, Eisenhauer, Elizabeth, Mirimanoff, René O., make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine 352 (10), S. 987-996. Volltext nicht vorhanden.